News Release

ロート製薬×太陽生命少子高齢社会研究所が初の共同意識調査。子どもの目の健康を意識する親は約6～7割

Regarding the conclusion of an exclusive domestic distribution agreement with PharmaBio Co., Ltd. for "PAL-222," a Regenerative medicine product currently under development for myopic chorioretinal atrophy.

Cordyceps sinensis, a traditional medicinal ingredient, is suggested to activate neural circuit formation and energy metabolism in the brain.

"THE THE LYPO," a beauty supplement containing two types of vitamin C—sustained-release and fast-acting—has been renewed.

Phase II investigator-initiated clinical trial of RE-01 cell therapy for refractory ischemic (non-arteriosclerotic) lower extremity ulcers caused by Buerger's disease and collagen diseases initiated.

The key to azelaic acid lies in "how it's dissolved." A low-irritation serum formulation demonstrating acne-fighting efficacy comparable to a 20% cream has been established.

Rohto Pharmaceutical has published the "ROHTO Well-being Report - Integrated Report 2026".

Announcement Regarding the Acquisition of OP Biofactory as a Subsidiary

Supporting the establishment of the "General Incorporated Association for the Study of Ectopic Fat."

Azelaic acid is now available in a serum that makes it easy to incorporate into your daily skincare routine. "AZA Clear® Serum" is now available from the medical institution-exclusive brand "DRX®".